1. Home
  2. SURG vs RFL Comparison

SURG vs RFL Comparison

Compare SURG & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

N/A

Current Price

$0.79

Market Cap

18.3M

ML Signal

N/A

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

N/A

Current Price

$1.49

Market Cap

61.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SURG
RFL
Founded
2006
2017
Country
United States
United States
Employees
20
N/A
Industry
Advertising
Real Estate
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
61.1M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
SURG
RFL
Price
$0.79
$1.49
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$9.75
N/A
AVG Volume (30 Days)
166.4K
89.3K
Earning Date
01-01-0001
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.28
EPS
N/A
N/A
Revenue
N/A
$917,000.00
Revenue This Year
$3.78
N/A
Revenue Next Year
$113.46
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.96
52 Week Low
$0.75
$1.12
52 Week High
$3.47
$3.19

Technical Indicators

Market Signals
Indicator
SURG
RFL
Relative Strength Index (RSI) 33.42 71.85
Support Level $0.75 $1.41
Resistance Level $0.95 $1.64
Average True Range (ATR) 0.06 0.10
MACD 0.03 0.03
Stochastic Oscillator 20.96 73.17

Price Performance

Historical Comparison
SURG
RFL

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: